Comparison between Novateor Research Laboratories IPO and Transpact Enterprises IPO.
Novateor Research Laboratories IPO is a SME Fixed Price IPO proposed to list at BSE SME while Transpact Enterprises IPO is a SME Fixed Price proposed to list at BSE SME.
| Novateor Research Laboratories IPO | Transpact Enterprises IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | First Overseas Capital Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Beeline Broking Ltd. | Aryaman Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Novateor Research Laboratories IPO is up to ₹4.26 Cr whereas the issue size of the Transpact Enterprises IPO is up to ₹1.27 Cr. The final issue price of Novateor Research Laboratories IPO is ₹24.00 per share and of Transpact Enterprises IPO is ₹130.00 per share.
| Novateor Research Laboratories IPO | Transpact Enterprises IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Final) | ₹24.00 per share | ₹130.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 6000 shares | 1000 shares |
| Fresh Issue Size | 17,76,000 shares | 98,000 shares |
| Fresh Issue Size (Amount) | up to ₹4.26 Cr | up to ₹1.27 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,76,000 shares | 98,000 shares |
| Issue Size Total (Amount) | up to ₹4.26 Cr | up to ₹1.27 Cr |
Novateor Research Laboratories IPO opens on Aug 30, 2019, while Transpact Enterprises IPO opens on Aug 26, 2019. The closing date of Novateor Research Laboratories IPO and Transpact Enterprises IPO is Sep 04, 2019, and Aug 28, 2019, respectively.
| Novateor Research Laboratories IPO | Transpact Enterprises IPO | |
|---|---|---|
| Issue Open | Aug 30, 2019 | Aug 26, 2019 |
| Issue Close | Sep 04, 2019 | Aug 28, 2019 |
| Basis Of Allotment (Tentative) | Sep 09, 2019 | Sep 03, 2019 |
| Initiation of Refunds (Tentative) | Sep 11, 2019 | Sep 04, 2019 |
| Credit of Share (Tentative) | Sep 12, 2019 | Sep 05, 2019 |
| Listing date (Tentative) | Sep 13, 2019 | Sep 05, 2019 |
Novateor Research Laboratories IPO P/E ratio is , as compared to Transpact Enterprises IPO P/E ratio of .
| Novateor Research Laboratories IPO | Transpact Enterprises IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.35% | 76.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 60.88% | 55.9% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹11.60 Cr. | ₹5.03 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Novateor Research Laboratories IPO Retail Individual Investors (RII) are offered 8,88,000 shares while in Transpact Enterprises IPO retail investors are offered 8,88,000 shares. Qualified Institutional Buyers (QIB) are offered in Novateor Research Laboratories IPO and in Transpact Enterprises IPO.
| Novateor Research Laboratories IPO | Transpact Enterprises IPO | |
|---|---|---|
| Market Maker Reservation | 96,000 shares | 6,000 shares |
| NII | 8,88,000 shares | 49,000 shares |
| RII | 8,88,000 shares | 49,000 shares |
| Total | 17,76,000 shares | 98,000 shares |
Novateor Research Laboratories IPO subscribed 1.24x in total, whereas Transpact Enterprises IPO subscribed 1.13x.
| Novateor Research Laboratories IPO | Transpact Enterprises IPO | |
|---|---|---|
| NII (times) | 1.80x | 0.90x |
| RII (times) | 0.67x | 1.37x |
| Total (times) | 1.24x | 1.13x |
